Document Classification

Section Type: METHODS

Text: This 52-week, open-label, randomized, multinational, multicentre trial included 310 subjects with type 2 diabetes (T2D) on premix, with or without metformin, who were randomized to a basal-bolus regimen with glargine and glulisine (n = 153 ; mean + / - s. d. age 60. 2 + / - 7. 5 years ; HbA1c 8. 6 + / - 0. 8 % ; weight 87. 0 + / - 15. 1 kg ; T2D duration 12. 8 + / - 5. 8 years) or twice-daily premix (n = 157 ; age 60. 9 + / - 7. 8 years ; HbA1c 8. 5 + / - 0. 9 % ; weight 84. 3 + / - 15. 0 kg ; T2D duration 12. 5 + / - 6. 8 years).